Decision Diagnostics Stock Alpha and Beta Analysis
| DECN Stock | USD 0.0001 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Decision Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Decision Diagnostics over a specified time horizon. Remember, high Decision Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Decision Diagnostics' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Decision |
Decision Diagnostics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Decision Diagnostics market risk premium is the additional return an investor will receive from holding Decision Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Decision Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Decision Diagnostics' performance over market.| α | 0.00 | β | 0.00 |
Decision Diagnostics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Decision Diagnostics' Buy-and-hold return. Our buy-and-hold chart shows how Decision Diagnostics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Decision Diagnostics Market Price Analysis
Market price analysis indicators help investors to evaluate how Decision Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Decision Diagnostics shares will generate the highest return on investment. By understating and applying Decision Diagnostics stock market price indicators, traders can identify Decision Diagnostics position entry and exit signals to maximize returns.
Decision Diagnostics Return and Market Media
The median price of Decision Diagnostics for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 1.0E-4 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | DGX - Quest Diagnostics Inc. Latest Stock News Market Updates - StockTitan | 01/30/2025 |
2 | Comparing Decision Diagnostics VeriSign | 02/19/2025 |
About Decision Diagnostics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Decision or other stocks. Alpha measures the amount that position in Decision Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2019 | 2020 | 2024 | 2025 (projected) | PTB Ratio | 24.89 | 9.92 | 8.93 | 9.38 | Price To Sales Ratio | 0.92 | 2.42 | 2.79 | 2.65 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Decision Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Decision Diagnostics' short interest history, or implied volatility extrapolated from Decision Diagnostics options trading.
Build Portfolio with Decision Diagnostics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Decision Diagnostics Backtesting, Decision Diagnostics Valuation, Decision Diagnostics Correlation, Decision Diagnostics Hype Analysis, Decision Diagnostics Volatility, Decision Diagnostics History and analyze Decision Diagnostics Performance. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Decision Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.